[Form 4] PRICE T ROWE GROUP INC Insider Trading Activity
Rhea-AI Filing Summary
The reporting person, Robert F. MacLellan, a director of T. Rowe Price Group, Inc. (TROW), received 161.0154 shares of common stock on 09/29/2025 under the company's 2017 Non-Employee Director Equity Plan as fully vested dividend reinvestment shares. After this automatic crediting the report shows beneficial ownership of 47,495.6698 shares. The transaction price listed is $103.52 per share, and the Form 4 was signed by an assistant corporate secretary acting under power of attorney on 09/30/2025. The filing reflects a routine, plan-driven reinvestment of dividends rather than an open-market purchase or sale.
Positive
- Director's ownership increased by 161.0154 shares through dividend reinvestment, bringing total beneficial holdings to 47,495.6698 shares.
Negative
- None.
Insights
TL;DR: Routine director dividend reinvestment credited as fully vested shares; standard for non-employee director equity plans.
This Form 4 documents an automatic, plan-based issuance of 161.0154 shares to a non-employee director under the 2017 Non-Employee Director Equity Plan. Such crediting of dividend reinvestment shares is typical and does not indicate active trading intentions or a change in board composition. The post-transaction holding of 47,495.6698 shares is disclosed, and the POA signature is properly noted. No derivative activity or disposals are reported.
TL;DR: Transaction is a non-market, dividend reinvestment event; immaterial to market-moving insider activity.
The Form 4 records an acquisition code 'A' for dividend reinvestment on 09/29/2025 and reports a per-share price of $103.52, consistent with plan accounting. Because the shares were credited as fully vested under the director plan, this is an administrative ownership increase rather than a discretionary purchase. There are no sales, option exercises, or derivative positions disclosed that would alter short-term insider exposure.